APIS Assay Technologies is leveraging the transformational power of systems biology and big data to directly address the historical failures of translating biomarkers into clinical utility.By linking genomic biomarker research and clinical history...
IPA is a biotherapeutic research and technology company that leverages network biology, multi-omics modelling and complex artificial intelligence systems for bioplatform-based antibody discovery —with the first universal solution to enable...
As one of Germany’s largest and best-known firms in the field of intellectual property (IP), providing optimal services to our clients is of paramount importance to us. Our team comprising about 250 people in Munich and Düsseldorf works closely with ...
Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers to...
Concr adopted established algorithms from cosmology to accurately predict patient-specific biomarkers of response to novel and existing cancer therapies.
Excelra provides data, insight, and R&D technology services to the world’s top pharmaceutical and biotech companies. From offices in Boston, Utrecht, London, and Hyderabad, Excelra’s 1000+ domain experts operate at the intersection of science...
MGME Neurotech provides neurobiological assessment and training solutions to combat the devastating effects of stress-related productivity loss, burnout, and turnover in the workplace.
Ntrack Biomedical AG strives towards improving the quality of life of patients by developing in-vitro diagnostic tests for early and non-invasive detection and monitoring of cancer. We can rapidly and inexpensively generate antibody based IVDs.
ApiniLabs will enable post-monolytic lab software by providing smart building blocks.
Aqsens Health is a Finnish biotech startup developing non-invasive screening tests for high-impact diseases. The company’s patented E-TRF method and biosensors provide new means for disease detection and biomarker discovery.
Arachne.ai is a biomedical data engine enabling ML/AI methods in drug discovery, allowing researchers to get ready-to-go datasets in a single line of code.
BatchX is a unique platform that offers a no-code solution for bioinformatics analysis and also serves as a marketplace.
Bioeureka's technology allows laboratory professionals and microbiologists to obtain results faster while being more efficient in their work.
BioFi’s proprietary virtual twin technology CellSim™ is a novel way to virtually engage and experiment with cell biology, to accelerate your research and optimize your products and processes.
We are a pioneer in AI mediated proximity inducing compound (PIC) engineering. We use cutting edge computational tools in conjunction with lab automation to tackle hard to drug diseases.
Best in class ophthalmic diagnostic system validated in a clinical trial. Can diagnose more eye diseases than competitors and supports multimodal diagnosis.
At Graphifi our team works closely with customers to really understand use cases, recommend and build appropriate solutions and help achieve the goal of showing business value quickly.
Hedera Dx is on a mission to simplify cancer testing globally and aims at transforming oncology by enabling routine use of liquid biopsies, one of the most transformational innovations in cancer care for the next decade.
iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development, to build a digital library of biomarkers and biological profiles.
At inSEIT, we work to remove the barriers that hamper the commercialization of immobilized enzymes and their integration in industrial conditions using our novel bioinformatic tools.
Iron Bridge is a contract research organization (CRO) that provides comprehensive support for clinical trials. Our core expertise lies in enabling efficient clinical trials in the fields of oncology and personalized medicine with the goal of...
At InkVivo we combine our biomaterial platform with advanced manufacturing approaches to fabricate novel drug delivery systems that ensure temporal controlled release of active ingredients.
Kairntech democratizes the way businesses transform text into actionable information: accessible to all, fast, accurate and fun to use. Build NLP pipelines and embed these within business applications.
KML Vision's IKOSA Platform equips life science researchers with a no-code solution using advanced AI for specialized bioimage analysis, delivering precise and reproducible results.
Your partner for multiomics data integration and analysis to accelerate disease biology research and target identification: Software and deeptech powered Analytics-as-a-Services.
We take the pain out of AI and Data Science with solutions we design and services we offer. Our T2R2, is the sole Platform that is Transparent, Traceable, Replicable and Reproducible (T2R2) by design.
mo:re is reducing the time to market for new therapies by replacing animal trials with AI-assisted cultivation of disease models, scaling up experiments without compromising traceability and quality.
Myndoor developed an innovative A.I. Model , capable of detecting clues of psychological stress, only by analyzing written communication. We can enable early stress and malaise detection before burnout arises.
Nemosia AG develops Positron Emission Tomography (PET) tracers targeting the NMDA receptor. Our tracers can provide early detection for neurodegenerative diseases such as Alzheimer's disease.
Our mission is to ensure the best possible outcome for patients by providing cancer-specific molecular diagnostic tests and monitoring solutions with a clear focus on actionable hot spot mutations.
Pixelshift is an extremely fast and fearlessly scalable image processing framework focused on biomedical analysis tasks such as pathology slide segmentation.
Popit makes medication connected with a unique solution, so patients get better treatment outcomes. Our certified platform increases adherence & engagement,and the customers include world’s largest pharma companies.
We developed a process to produce human organoids from adult mesenchymal stem cells in real microgravity in space which makes them bigger and better differentiated than organoids produced on Earth. Apart from that, the quality is consistently high...
GPT-4 of Radiology: Raidium is a Medtech startup developing the first ever radiological foundation model to tackle the complexity of precision medicine.
Rapid Fluidics provides microfluidic design, prototyping and manufacturing services using a novel approach to rapidly and accurately produce microfluidic test cards.
ReviveMed is an MIT spun-out, AI-based metabolomic platform for precision medicine, leveraging 20x more metabolic data than any other platform. With data from 78,000+ patients, we have partnered with biopharma, e.g. BMS.
The scopeDx® CRISPR based molecular detection platform offers on-site DNA or RNA identification with incredible sensitivity and specificity, for use in diagnostics and genotyping applications.
SoftMining is an AI-powered drug discovery company that designs new molecules for therapeutics. Our mission is to generate new molecules to address medical needs.
A sensitive HIV-1 nucleic acid quantification assay has been developed, patented, and published (Kibirige et al. Sci Reps 2022). It has been validated according to US FDA guidelines for viral load assays and shown to have broad cross-subtype...
Thot builds tools that automate data management and analysis for scientific researchers. Using our tools, their science becomes open for reuse and debate.
Transmineo enables the demonstration of real-world value that addresses payer concerns, supporting a smart future proof commercialization model for orphan medicines that contributes to solving the inequality of access in Europe.
UNOMR is a BioTech ETH spin-off that provides a patented, next-generation serial nanopore-sensor for single-molecule protein analysis and sequencing. We envision true personalized medicine based on proteomics.
Vector, a University of Cambridge spin-out, is revolutionizing cancer therapy with our RNA delivery platform. Our technology protects and delivers RNA directly to the tumour, with a controlled release, mitigating side effects.
xtendr enables teams and organizations to share datasets - and find insights in their combined data - in a secure and compliant way, for improved research and diagnostics, and better patient outcomes.